[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cancer-survivor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cancer-survivor":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,54,85,124,149,177,204,235],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":32,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100582839","leading-healthy-eating-and-activity-promotion-program-100582839",false,"NCT06868524","Leading Healthy Eating and Activity Promotion Program","Leveraging Adaptation and Multilevel Implementation Strategies to Address Unique Health Promotion Challenges Among Cancer Survivors","LEAP","Inclusion Criteria:\n\n* Between the ages of 18 and 89\n* English speaking\n* Resident of Birmingham area or surrounding community\n* History of any type of cancer or the friend or family with of a cancer survivor\n\nExclusion Criteria:\n\n* Serious difficulty hearing\n* History of dementia or organic brain syndrome\n* On primary treatment for cancer\n* No other other medical, psychological, or social characteristic that would interfere with participation in evaluation",true,"ALL","18 Years","89 Years",{"count":22,"type":23},100,"ESTIMATED","INTERVENTIONAL",[26],"NA","The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support. This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet and regular physical activity into a program for cancer survivors and co-survivors that is appropriate for the persistent poverty context and social determinants of health.",[29,30,31],"Cancer Survivor","Cancer","Oncology",[33,34,35,36,37,38,39,40],"cancer survivor","cancer","oncology","exercise","nutrition","diet","healthy lifestyle","behavior change","RECRUITING","2026-05-14",{"date":44,"type":45},"2026-05-19","ACTUAL",{"date":47,"type":45},"2025-10-30",{"date":49,"type":23},"2029-03-01",{"name":51,"class":52},"University of Alabama at Birmingham","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":61,"enrollmentInfo":62,"targetDuration":4,"studyType":24,"phases":64,"briefSummary":66,"conditions":67,"keywords":70,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":84},"100560197","phase-4-better-options-for-chronic-cancer-pain-100560197","NCT06574009","Better Options for Chronic Cancer Pain","Better Options for Chronic Cancer Pain: a SMART Study","Inclusion Criteria:\n\n* Veterans must have had a qualifying solid tumor (bladder, breast, colorectal, head and neck, liver, lung, pancreas, prostate, or urinary tract) without evidence of active disease for at least 6 months\n* Participants must be 6 months away from their last receipt of cytotoxic, radiation, or surgical cancer treatments but can be on hormonal or biologic therapies needed to sustain remission or cancer control.\n* Participants must report pain \\>=4 (on 0-10 NRS) on their last 3 recordings in the electronic medical record. Veterans should be on Long Term Opioid Therapy (LTOT) defined as:\n\n  * a qualifying opioid analgesic dispensed within the prior 30 days\n  * plus 150 days' supply of a qualifying opioid (fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, oxymorphone) in the 180 days before the most recent dispensing date with no between-fill gaps \\>40 days\n* There must be advance agreement from their existing opioid prescriber to resume opioid prescribing after study\n\nExclusion Criteria:\n\n* Veterans with total daily opioid doses \\>= 300 Morphine Milligram Equivalents (MME) will be excluded (higher doses require tapering prior to rotation to buprenorphine, which is something the investigators do not want to examine in this study)\n* Veterans with referrals or visits to a substance abuse clinic within the prior 2 years will be excluded to avoid including individuals requiring addiction expertise that is not available one the multidisciplinary pain teams\n* The investigators will also exclude Veterans with:\n\n  * current or past use of buprenorphine\n  * active alcohol use disorder or substance use\n  * risk factors for opioid overdose (e.g. active suicidality or history of self-directed violence)\n  * daily use of benzodiazepines\n  * receipt of opioids from non-VA providers in the prior 3 months\n  * or aberrant urine drug screen at baseline (cannabis is not exclusionary)\n* To ensure the relevance of our work to as many Veteran cancer survivors as possible, the investigators will not exclude subjects meeting DSM criteria for opioid use disorder if their only source of opioids is the VA","99 Years",{"count":63,"type":23},294,[65],"PHASE4","This proposal is relevant to the 240,000 cancer survivors who continue to use opioids long after they have successfully completed treatment for cancer at the VHA, placing them at risk of opioid addiction and overdose, and other opioid-related problems. Yet, there are no programs at the VHA to help them find alternatives to opioids, nor evidence to inform the choice of interventions. This study will meet these needs by examining four interventions that are effective at reducing opioid use in patients with chronic musculoskeletal pain but have yet to be tested in cancer survivors on long term opioid therapy. The proposed work is relevant to the VHA Pain Office's mission to provide Veterans better pain management while limiting the risks of long-term opioid therapy and it aligns with VHA Research and Development's priority to examine clinical interventions for tapering opioids. Successful completion this project will keep VHA at the forefront of the battle against the opioid epidemic with a strategy that may be adapted to address the same needs in non-Veterans.",[68,29,69],"Chronic Pain","Opioid Dependence",[71,72,73],"survivorship","chronic pain","analgesics","2026-05-07",{"date":76,"type":45},"2026-05-11",{"date":78,"type":45},"2025-10-07",{"date":80,"type":23},"2029-12-31",{"name":82,"class":83},"VA Office of Research and Development","FED",2,{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":89,"acronym":4,"eligibilityCriteria":90,"healthyVolunteers":11,"sex":91,"minAge":19,"maxAge":4,"enrollmentInfo":92,"targetDuration":4,"studyType":24,"phases":94,"briefSummary":95,"conditions":96,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":118,"completionDateStruct":120,"leadSponsor":122,"locationsCount":53},"100353326","nutrition-and-exercise-interventions-for-androgen-deprivation-therapy-induced-obese-frailty-in-elderly-and-non-elderly-survivors-of-advanced-prostate-cancer-100353326","NCT03880422","Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer","Inclusion Criteria:\n\n* Biopsy-confirmed prostate adenocarcinoma of any stage\u002Fgrade\n* Prescribed or already receiving continuous ADT for \\\u003C 5 years\n* Hemoglobin \\> 11 g\u002FdL\n* Creatinine \\\u003C 1.5 x upper limit of normal (ULN), AST or ALT \\\u003C2 x ULN within 6 months prior to enrollment\n* Liver function tests \\\u003C 2 x ULN\n* Able to walk unassisted at least 100 meters (200 steps) or ECOG \\\u003C= 1\n* No contraindications to any aspect of participation, including aerobic exercise\n* Participant must be able to read, write, and understand the English language and be able to provide written consent\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee\u002FInstitutional Review Board approved written informed consent form prior to receiving any study related procedure\n\nExclusion Criteria:\n\n* Known clinically significant severe chronic obstructive pulmonary disease (COPD), ischemic heart disease, congestive heart failure, and\u002For significant cardiac arrhythmias\n* Limiting orthopedic, musculoskeletal or psychological conditions (clinician discretion)\n* Overall medical frailty (clinician discretion)\n* Any condition contraindicating additional blood collection beyond standard of care\n* Unwilling or unable to follow protocol requirements\n* Any condition which in the investigator's opinion deems the participant an unsuitable candidate to receive study intervention","MALE",{"count":93,"type":23},50,[26],"This trial studies how well nutrition and exercise interventions work in reducing androgen deprivation therapy-induced obese frailty in prostate cancer survivors. Individualized nutrition and exercise advice for prostate cancer patients on androgen deprivation therapy may help to reduce obese frailty and change the levels of myokines in blood.",[29,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115],"Obesity","Overweight","Prostate Adenocarcinoma","Stage A Prostate Cancer","Stage B Prostate Cancer","Stage C Prostate Cancer","Stage D Prostate Cancer","Stage I Prostate Cancer","Stage II Prostate Cancer","Stage IIA Prostate Cancer","Stage IIB Prostate Cancer","Stage IIC Prostate Cancer","Stage III Prostate Cancer","Stage IIIA Prostate Cancer","Stage IIIB Prostate Cancer","Stage IIIC Prostate Cancer","Stage IV Prostate Cancer","Stage IVA Prostate Cancer","Stage IVB Prostate Cancer","2026-05-01",{"date":74,"type":45},{"date":119,"type":45},"2019-05-02",{"date":121,"type":23},"2029-05-02",{"name":123,"class":52},"Roswell Park Cancer Institute",{"id":125,"slug":126,"hasResults":11,"nctId":127,"briefTitle":128,"officialTitle":129,"acronym":4,"eligibilityCriteria":130,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":131,"targetDuration":4,"studyType":24,"phases":133,"briefSummary":134,"conditions":135,"keywords":136,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":140,"lastUpdatePostDateStruct":141,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":84},"100578721","an-acupuncture-study-for-cancer-survivors-with-joint-pain-100578721","NCT06814977","An Acupuncture Study for Cancer Survivors With Joint Pain","Researching the Implementation of Acupuncture for Chronic Musculoskeletal Pain in Diverse Underserved Cancer Survivors (ReIMAGINE)","Inclusion Criteria:\n\n* English- or Spanish-speaking adults\n* Non white or Hispanic women with a prior cancer diagnosis\n* Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment\n* Worst pain rated ≥4 on a 0-10 scale in the preceding week\n* ≥15 days with pain in the past 30 days\n* Pain lasting ≥1 month\n* Willing and able to complete questionnaires and other study activities\n* Willing and able to provide informed consent for the trial\n\nExclusion Criteria:\n\n* Completed active treatment (chemotherapy, surgery, radiation, transplantation) \\\u003C4 weeks prior to study\n* Maintenance therapies are allowed\n* Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)\n* Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain\n* Procedures involving affected joints within the last month or planned in the next 14 weeks\n* Acupuncture use for pain in the past three months\n* Implanted electronic device (e.g., pacemaker)",{"count":132,"type":23},60,[26],"The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.",[29],[137,138,34,139],"history of cancer","acupuncture","24-305","2025-10-09",{"date":142,"type":45},"2025-10-10",{"date":144,"type":45},"2025-01-31",{"date":146,"type":23},"2028-06-30",{"name":148,"class":52},"Memorial Sloan Kettering Cancer Center",{"id":150,"slug":151,"hasResults":11,"nctId":152,"briefTitle":153,"officialTitle":154,"acronym":155,"eligibilityCriteria":156,"healthyVolunteers":11,"sex":157,"minAge":158,"maxAge":4,"enrollmentInfo":159,"targetDuration":4,"studyType":24,"phases":161,"briefSummary":162,"conditions":163,"keywords":166,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":169,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":84},"100573353","making-healthy-habits-stick-100573353","NCT06745180","Making Healthy Habits Stick","Making Healthy Habits Stick: Extended Contact Interventions to Promote Long-Term Physical Activity in Cancer Survivors","HABITS","Inclusion Criteria:\n\n* woman age of 19 or older\n* identifies as African American or Black\n* have a history of cancer\n* have completed post-primary treatment for cancer (i.e., chemotherapy, radiation)\n* agree to allow research team to confirm cancer diagnosis with your physician\n* If received surgery, must be at least 8 weeks post-surgery\n* willing to have regular physician provide medical clearance for study participation\n* willing to provide home address if qualified for the study\n* willing and able to use videoconference platform such as Zoom for study activities (must be both willing and able)\n* willing and able to send and\u002For receive text messages (must be both willing and able)\n* has US phone number\n* has an email address\n* if has no email address, must be willing to create one\n* English speaking\n* Able to ambulate without assistance (does not need to use a cane, a walker, or a wheelchair)\n* willing and able to complete 3-5 exercise session per week on their own for the duration of the study; if answered no, please explain\n* willing to attend individual and group sessions via videoconferences during study participation; if answered no, please explain.\n* willing to attend assessments via videoconference during study participation; if answered no, please explain.\n* willing to complete surveys during study participation; if answered no, please explain.\n\nExclusion Criteria:\n\n* Metastatic or recurrent cancer\n* another cancer diagnosis in the past 5 years (not including skin or cervical cancer in situ)\n* have severe orthopedic, joints or any other condition that stops individual from being active\n* unstable angina\n* have paint, tightness, or heaviness in chest EITHER when resting OR then physically active\n* have New York Heart Association class II, III, OR IV congestive heart failure\n* blood pressure has been over 160\u002F100 at least twice in the past 6 months (either number; 160 or 100)\n* have uncontrolled asthma\n* have interstitial lung disease that requires extra oxygen\n* have dementia or organize brain syndrome\n* have schizophrenia or active psychosis\n* have had a stroke or other problem that left individual disables or with paralysis (unable to move or feel any part of body)\n* have hearing problems that make it hard to carry on a phone conversation\n* blind or partially blind\n* planned surgery during the first 6 month of study participation (if unapproved by PI)\n* planned knee or hip surgery during the first 6 month of study participation\n* anticipate changes in usual medications during the first 6 months of study participation (if unapproved by PI)\n* have been told by a physician to only do exercise prescribed by a physician\n* have been told by a physician to limit physical activity\n* have a contraindication to engaging in moderate intensity aerobic exercise\n* have completed on average, more than 90 min\u002Fweek of moderate-intensity or more that 30 min\u002Fweek of vigorous exercise in the past 6 months\n* trouble with balance or moving around safely\n* are currently pregnant or anticipate pregnant during study participation\n* currently participating in another exercise study\n* have BMI ≥ 50","FEMALE","19 Years",{"count":160,"type":23},260,[26],"The aim of this project is to help increase physical activity maintenance in cancer survivors.",[30,164,29,165],"Physical Activity","Cancer Survivorship",[164,30,29,167,165],"Exercise","2025-09-26",{"date":170,"type":45},"2025-10-01",{"date":172,"type":45},"2025-01-27",{"date":174,"type":23},"2028-03-31",{"name":176,"class":52},"University of Tennessee",{"id":178,"slug":179,"hasResults":11,"nctId":180,"briefTitle":181,"officialTitle":182,"acronym":183,"eligibilityCriteria":184,"healthyVolunteers":17,"sex":18,"minAge":4,"maxAge":4,"enrollmentInfo":185,"targetDuration":4,"studyType":187,"phases":4,"briefSummary":188,"conditions":189,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":194,"lastUpdatePostDateStruct":195,"startDateStruct":197,"completionDateStruct":199,"leadSponsor":201,"locationsCount":203},"100357342","studying-health-outcomes-after-treatment-in-patients-with-retinoblastoma-100357342","NCT03932786","Studying Health Outcomes After Treatment in Patients With Retinoblastoma","Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)","RIVERBOAT","* Unilateral or bilateral intraocular retinoblastoma\n* Diagnosis between the ages of 0 - 17.99 years\n* Diagnosis on or after January 1, 2008\n* No exclusions based on primary or secondary treatment modalities\n* Retrospective group patients must be ≥ 6 months post end of treatment at study entry\n\n  * For those already at this timepoint, they are now eligible\n  * For those in treatment, or otherwise not yet at this timepoint, they are eligible once at they are ≥ 6 months post end of treatment\n  * Prospective group patients must not have begun treatment\n* Patients with diminished capacity will not be enrolled.\n* Language: Patients must be able to communicate in English, French, or Spanish\n* Sibling Cohort: One sibling, not affected by retinoblastoma will be enrolled, preference for the sibling closest in age to the RB patient.\n* Regulatory Requirements: All patients and\u002For their parents or legal guardians must sign a written informed consent. All institutional, FDA, and NCI requirements for human studies must be met.",{"count":186,"type":23},900,"OBSERVATIONAL","This trial studies health outcomes after treatment in patients with retinoblastoma. Gathering health information over time from patients and family members through vision assessments, samples of tissue and saliva, and questionnaires may help doctors learn more about what causes retinoblastoma, identify long-term health outcomes for patients with retinoblastoma, and find out which therapies may be the best for treating retinoblastoma",[190,29,191,192,193],"Retinoblastoma","Biological Sibling","Intraocular Retinoblastoma","Unilateral Retinoblastoma","2025-09-15",{"date":196,"type":45},"2025-09-19",{"date":198,"type":45},"2019-01-24",{"date":200,"type":23},"2031-01",{"name":202,"class":52},"Vanderbilt-Ingram Cancer Center",11,{"id":205,"slug":206,"hasResults":11,"nctId":207,"briefTitle":208,"officialTitle":209,"acronym":210,"eligibilityCriteria":211,"healthyVolunteers":11,"sex":18,"minAge":212,"maxAge":4,"enrollmentInfo":213,"targetDuration":4,"studyType":24,"phases":215,"briefSummary":216,"conditions":217,"keywords":220,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":225,"lastUpdatePostDateStruct":226,"startDateStruct":228,"completionDateStruct":230,"leadSponsor":232,"locationsCount":53},"100588278","log-i---impact-study-of-log-after-software-on-long-term-monitoring-of-former-patients-log-i---log-impact-study-100588278","NCT06939322","LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study)","LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) \u002F Etude d'Impact du Logiciel LOG-AFTER Sur le Suivi à Long Terme Des Anciens Patients (LOG-I - LOG-Impact Study)","LOG-I","Inclusion Criteria:\n\n* Previously treated for cancer or malignant hematological pathology before the age of 25\n* Without residual disease or with a stable disease without treatment for 5 years or more\n* Owning a computer, smartphone or equivalent I-Pad\u002Ftablet with internet access\n* Having signed the consent (or their parents if the patient is a minor, or a third party if necessary)\n* Having 3 or more recommended screenings in their survivorship care plan\n* No access created to LOG-AFTER before the study or having never connected after opening their account if opening an account dating back 24 months or more at the time of inclusion\n\nExclusion Criteria:\n\n* Patient who has relapsed or developed a second cancer with a post-treatment delay \\\u003C 5 years\n* Patient not covered by a health insurance\n* Patient subject to a legal protection measure, patient deprived of liberty by judicial or administrative decision, patient subject to psychiatric care under duress","15 Years",{"count":214,"type":23},320,[26],"Childhood cancer survivors represent a high-risk population that requires risk-based follow-up. Follow-up recommendations have been harmonized. Education and information practices regarding follow-up recommendations should be personalized, to ensure understanding by all survivors, including those with neurocognitive disorders. Individualized follow-up is necessary to detect complications that may increase morbidity and decrease quality of life, or even increase the risk of early mortality.\n\nIn France, the LOG-AFTER software was developed in 2017 by university hospital of Angers and Epiconcept (approved health data host). The main differences with the European procedure concern radiotherapy information, the link with the General practitioner (GP), and the possible addition of information and\u002For access to therapeutic education in a video format. Indeed, there is the possibility of creating an GP account allowing to receive notifications concerning the follow-up of his patient to be scheduled, to have access to his file summary and his personalized follow-up plan, various information and blank prescription models. LOG-I is a study of the impact of the LOG-AFTER software for the \"patient\u002FGP\" couple on adherence to follow-up recommendations. LOG-I is interested in all former patients with at least 3 recommendations in their personalized follow-up plan, taking into account the specific population of patients cured of a brain tumor.",[218,29,219],"Pediatric Cancer","Hemato-oncologic Patients",[221,35,222,223,71,224],"pediatry","hematology","radiotherapy","preventive care","2025-06-27",{"date":227,"type":45},"2025-07-02",{"date":229,"type":45},"2025-06-06",{"date":231,"type":23},"2030-06-06",{"name":233,"class":234},"University Hospital, Angers","OTHER_GOV",{"id":236,"slug":237,"hasResults":11,"nctId":238,"briefTitle":239,"officialTitle":240,"acronym":241,"eligibilityCriteria":242,"healthyVolunteers":17,"sex":18,"minAge":243,"maxAge":19,"enrollmentInfo":244,"targetDuration":4,"studyType":24,"phases":246,"briefSummary":247,"conditions":248,"keywords":253,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":257,"lastUpdatePostDateStruct":258,"startDateStruct":260,"completionDateStruct":261,"leadSponsor":263,"locationsCount":53},"100355897","health-and-exercise-response-in-children-with-chronic-and-auto-immune-pathologies-100355897","NCT03913962","Health and Exercise Response in Children With Chronic and Auto-immune Pathologies","Evaluation of Chronic Pathologies Impact and Their Treatments on Children and Teen Physical Fitness.","HERCCULE","Inclusion Criteria:\n\n* for patients:\n* Aged between 6 and 18-year-old\n* Male or female\n* Presenting a chronic pathology \u002F having a treatment which is known to alter muscle mass and function, metabolism and body composition\n* Included in the active list of the hospital centre of Clermont-Ferrand\n* Free and informed consent of the holders of parental authority and the patient\n* Affiliated with the social security system for control:\n* Aged between 6 and 18-year-old\n* Male or female\n* Free and informed consent of the holders of parental authority and the patient\n* Affiliated with the social security system\n\nExclusion Criteria:\n\n* for patients:\n* Treatment by systemic corticoids (\\>1 week in the 30 days before test)\n* Contraindication to sport practice\n* Active infection for control:\n* Contraindication to sport practice\n* Chronic pathology susceptible to alter muscle mass and function, metabolism and body composition\n* Treatment susceptible to alter metabolism\n* Active infection","6 Years",{"count":245,"type":23},300,[26],"The aim of the present project is to assess the effects of the chronic diseases and their associated treatments chronic paediatric diseases (CPD), to further understand their impact on physical fitness for public health perspectives. This is an innovative approach in the treatment of chronic paediatric diseases . This project should yield results that help improving treatments for children and adolescents with chronic paediatric diseases throughout physical activity as therapy, reduced pain, fatigue and inflammation, and improvement in physical fitness and life quality. The originality and novelty of this project is to combine architectural, functional and metabolic components of skeletal muscle to further understand the impact of chronic paediatric diseases as a function of treatment, disease activity and maturation status (prepubertal, pubertal or post pubertal).\n\nThis study will aim at assessing muscular function (force production capacity and fatigability) in specific or ecologic situations so as to get information about muscle functioning on isolated muscle group (here knee extensors) or during whole body exercise. Moreover, results arising from muscle architecture or quality will allow understanding the decrease in strength or endurance reported in the literature. The data collected will allow us to further understand the impact of the disease on structural, functional and metabolic parameters. Finally, the understanding of these alterations will provide information enabling to establish recommendations in physical activity (PA) to reduce or even counter the effect of the chronic inflammation and prevent at long-term overweight and cardiovascular risks.\n\nThe long-term objective is to contribute establishing recommendations or guidelines for prescribing physical activity during medical therapy. Values obtained in pathological children will be compared to those of control children matched for gender and maturation.",[249,250,251,29,252],"Juvenile Idiopathic Arthritis","Diabetes","Inflammatory Bowel Disease","Anorexia Nervosa",[254,255,256,164],"Paediatric","Auto-immunity","Treatment","2019-05-06",{"date":259,"type":45},"2019-05-08",{"date":119,"type":45},{"date":262,"type":23},"2028-12-31",{"name":264,"class":52},"University Hospital, Clermont-Ferrand"]